Popular filter options for new orleans trials
Phase 3 Clinical Trials
View 93 phase 3 medical studies.
Corticosteroid
Budesonide +1 More for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Gulfport, Mississippi
This trial will compare the effect of using a combination inhaler (BGF) containing three types of medication versus a different combination inhaler (GFF) in people with COPD and high risk for
Janus Kinase Inhibitor
Povorcitinib for Hidradenitis Suppurativa
Recruiting2 awardsPhase 3
Metairie, Louisiana
This trial aims to assess the safety and effectiveness of povorcitinib over a long period in people with moderate to severe hidradenitis suppurativa who have already completed 54 weeks of treatment
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Dapagliflozin +1 More for Type 2 Diabetes
Recruiting2 awardsPhase 3
Marrero, Louisiana
This trial will compare the safety and effectiveness of orforglipron and dapagliflozin in helping people with type 2 diabetes control their blood sugar levels. The trial will last for about
Clinical Trials With No Placebo
View 93 medical studies that do not have a placebo group.
Corticosteroid
Budesonide +1 More for Chronic Obstructive Pulmonary Disease
Recruiting2 awardsPhase 3
Gulfport, Mississippi
This trial will compare the effect of using a combination inhaler (BGF) containing three types of medication versus a different combination inhaler (GFF) in people with COPD and high risk for
Cancer Vaccine
RSV/hMPV mRNA LNP 1 +3 More for Metapneumovirus Infection
Recruiting1 awardPhase 1
Metairie, Louisiana
This trial aims to test a new vaccine to prevent lower respiratory tract diseases caused by respiratory syncytial virus and human metapneumovirus in older adults. Participants will receive one injection of the
Pulsatile insulin at 40mU/m2/min for Insulin Sensitivity
Recruiting1 award
Baton Rouge, Louisiana
This trial will compare two methods of measuring insulin sensitivity. Insulin is a hormone that helps control blood sugar levels. The current standard method involves continuously infusing insulin, while the new method involves infusing
Janus Kinase Inhibitor
Povorcitinib for Hidradenitis Suppurativa
Recruiting2 awardsPhase 3
Metairie, Louisiana
This trial aims to assess the safety and effectiveness of povorcitinib over a long period in people with moderate to severe hidradenitis suppurativa who have already completed 54 weeks of treatment
View More New Orleans Trials
See another 78 medical studies focused on new orleans.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.